Pierre DEHARO, Medical Doctor, MD PhD

Por um escritor misterioso
Last updated 11 junho 2024
Pierre DEHARO, Medical Doctor, MD PhD
Pierre DEHARO, Medical Doctor, MD PhD
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome - ScienceDirect
Pierre DEHARO, Medical Doctor, MD PhD
Interactive Speaker
Pierre DEHARO, Medical Doctor, MD PhD
Dr. Alexandros Briasoulis, MD – Rochester, MN
Pierre DEHARO, Medical Doctor, MD PhD
Pierre Deharo
Pierre DEHARO, Medical Doctor, MD PhD
incathlab on LinkedIn: #coronary #microcirculation #pci #microvascular #health #cardiology
Pierre DEHARO, Medical Doctor, MD PhD
Dr. Kenneth A. Ellenbogen, MD, Richmond, VA, Cardiologist
Pierre DEHARO, Medical Doctor, MD PhD
Pierre MORANGE, Chef de service, MD - PhD, Aix-Marseille Université, Marseille, AMU, Faculté de Médecine
Pierre DEHARO, Medical Doctor, MD PhD
EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology. - EuroIntervention
Pierre DEHARO, Medical Doctor, MD PhD
Outcomes associated with pacemaker implantation following transcatheter aortic valve replacement: A nationwide cohort study - ScienceDirect

© 2014-2024 khosatthep.net. All rights reserved.